{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:57:35Z","timestamp":1760245055632,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.humpath.2020.10.013","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T02:11:18Z","timestamp":1604628678000},"page":"46-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Renal neoplasia with papillary architecture involving the pelvicalyceal system"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda K.","family":"Galeano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Sukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren","family":"Herrera-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn A.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Houston","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.10.013_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bju.13669","article-title":"Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma","volume":"119","author":"Bailey","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2020.10.013_bib2","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/S0022-5347(05)64991-9","article-title":"Renal cell carcinoma invading the urinary collecting system: implications for staging","volume":"167","author":"Uzzo","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2020.10.013_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/his.13743","article-title":"Renal cell carcinoma staging: pitfalls, challenges, and updates","volume":"74","author":"Williamson","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.10.013_bib4","doi-asserted-by":"crossref","first-page":"21325","DOI":"10.1038\/srep21325","article-title":"Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2020.10.013_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.ju.0000082580.13597.a2","article-title":"Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies","volume":"170","author":"Palapattu","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2020.10.013_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.juro.2009.05.017","article-title":"Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma","volume":"182","author":"Verhoest","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2020.10.013_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.eururo.2004.07.006","article-title":"Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma","volume":"46","author":"Terrone","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2020.10.013_bib8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-08-1229","article-title":"Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma","volume":"15","author":"Klatte","year":"2009","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.10.013_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41379-019-0269-x","article-title":"JAK2\/PD-L1\/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management","volume":"32","author":"Gupta","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","article-title":"TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients","volume":"36","author":"Sukov","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/modpathol.2013.83","article-title":"Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases","volume":"27","author":"Hodge","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib15","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.humpath.2020.10.013_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Canc Discov"},{"key":"10.1016\/j.humpath.2020.10.013_bib17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"RBM10-TFE3 renal cell carcinoma: a potential diagnostic pitfall due to cryptic intrachromosomal Xp11.2 inversion resulting in false-negative TFE3 FISH","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.23900","article-title":"Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma","volume":"41","author":"Zhang","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2020.10.013_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mayocp.2020.01.026","article-title":"Fumarate hydratase-deficient renal cell carcinoma","volume":"95","author":"Gupta","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2020.10.013_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2020.10.013_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-Fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib22","first-page":"e449","article-title":"A rare finding of a BRAF mutation in renal cell carcinoma with response to BRAF-directed targeted therapy","volume":"8","author":"Banerjee","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.humpath.2020.10.013_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.05.051","article-title":"BRAF mutations in metanephric adenoma of the kidney","volume":"62","author":"Choueiri","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2020.10.013_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41379-019-0420-8","article-title":"Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma","volume":"33","author":"Kim","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.10.013_bib27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/1066896920918289","article-title":"Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 7 cases","volume":"28","author":"Zhou","year":"2020","journal-title":"Int J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720302185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720302185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:38Z","timestamp":1758645458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720302185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"alternative-id":["S0046817720302185"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.10.013","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal neoplasia with papillary architecture involving the pelvicalyceal system","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}